Maio Michele, Fonsatti Ester, Burigo Arianna, Parmiani Giorgio
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.
Tumori. 2008 Mar-Apr;94(2):179-81. doi: 10.1177/030089160809400208.
In the context of the Scientific Week 2008 of the Organisation of the European Cancer Institutes, the Italian Network for Tumor Biotherapy (NIBIT), within its initiatives sponsored by Alleanza Contro il Cancro, the Italian Network of Comprehensive Cancer Centers has contributed to organize the Workshop of the European Networks for bio-immunotherapy of tumors. Representatives from the Nordic Center of Excellence for the Development of Anti-Tumor Vaccines (Sweden), the German Network of Immunotherapy of Tumors (Germany), the Biotherapy Development Association and NIBIT gathered to present their organization and ongoing scientific activities, as well as to identify common strategies and shared efforts to push the field of cancer bio-immunotherapy forward at a European level. This article briefly summarizes the history and objectives of NIBIT, along with the actions so far taken by the Network.
在欧洲癌症研究所组织的2008年科学周背景下，意大利肿瘤生物治疗网络（NIBIT）在由意大利抗癌联盟赞助的倡议活动中，意大利综合癌症中心网络为组织肿瘤生物免疫治疗欧洲网络研讨会做出了贡献。来自北欧抗肿瘤疫苗研发卓越中心（瑞典）、德国肿瘤免疫治疗网络（德国）、生物治疗发展协会和NIBIT的代表齐聚一堂，介绍各自的组织情况和正在开展的科学活动，并确定共同战略和共同努力方向，以在欧洲层面推动癌症生物免疫治疗领域向前发展。本文简要总结了NIBIT的历史和目标，以及该网络迄今采取的行动。
